Adherence to mediterranean diet and risk of breast cancer in premenopausal and postmenopausal women

Archives of Iranian Medicine

Volumn 18, Issue 11, 2015, Pages 786-792

  Farsinejad Marj, Maryam ^a,b   Talebi, Shokufeh ^a,b   Ghiyasvand, Reza ^a,b   Miraghajani, Maryam ^a,b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast cancer; Mediterranean diet; Postmenopausal women; Premenopausal women

Indexed keywords

ESTROGEN RECEPTOR; HORMONE RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; BODY MASS; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; DIETARY COMPLIANCE; ETHNICITY; FEMALE; FOOD INTAKE; HUMAN; MEDITERRANEAN DIET; MENOPAUSE; NUTRITIONAL ASSESSMENT; POSTMENOPAUSE; PREMENOPAUSE; QUESTIONNAIRE; SYSTEMATIC REVIEW; BREAST NEOPLASMS; COHORT ANALYSIS; HEALTH PROMOTION; RISK FACTOR;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; DIET, MEDITERRANEAN; FEMALE; HEALTH PROMOTION; HUMANS; POSTMENOPAUSE; PREMENOPAUSE; RISK FACTORS;

EID: 84944730343     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Estimated cancer incidence, mortality and prevalence worldwide in 2012. Retrieved September 2013; Available from: URL: http://globo-can.iarc.fr/pages/fact_sheets_cancer.aspx.
2. Shi J, Tong J, Cai S, Qu X, Liu Y. Correlation ofthe BACH1 Pro919Ser polymorphism with breast cancer risk: A literature-based meta-analysis and meta-regression analysis. Exp TherMed. 2013; 6: 435-444.
3. Botrel TE, Paladini L, Clark OA. Lapatinib plus chemotherapy or endocrine therapy (CET) versus CET alone in the treatment of HER-2-overexpressing locally advanced or metastatic breast cancer: systematic review and meta-analysis. CoreEvid. 2013; 8: 69-78.
4. Escrich E, Solanas M, Moral R, Escrich R. Modulatory effects and molecular mechanisms of olive oil and other dietary lipids in breast cancer. CurrPharmDes. 2011; 17: 813-830.
5. Michels KB, Mohllajee AP, Roset-Bahmanyar E, Beehler GP, Moy-sich KB. Diet and breast cancer: A review of the prospective observational studies. Cancer. 2007; 109: 2712-2749.
6. Couto E, Sandin S, Lof M, Ursin G, Adami HO, Weiderpass E. Mediterranean dietary pattern and risk of breast cancer. PLoS One. 2013; 8: e55374.
7. Sewell DA, Hammersley VS, Devereux G, Robertson A, Stoddart A, Weir C et al. Investigating the effectiveness of the Mediterranean diet in pregnant women for the primary prevention of asthma and allergy in high-risk infants: protocol for a pilot randomised controlled trial. Trials. 2013; 14: 173.
8. Demetriou CA, Hadjisavvas A, Loizidou MA, Loucaides G, Neo-phytou I, Sieri S, et al. The mediterranean dietary pattern and breast cancer risk in Greek-Cypriot women: A case-control study. BMC Cancer. 2012; 12: 113.
9. Buckland G, Travier N, Cottet V, González CA, Luján-Barroso L, Agudo A, et al. Adherence to the Mediterranean diet and risk of breast cancer in the European prospective investigation into cancer and nutrition cohort study. Int J Cancer. 2013; 132: 2918-2927.
10. Bonanni AE, Bonaccio M, di Castelnuovo A, de Lucia F, Costanzo S, Persichillo M, et al. Food labels use is associated with higher adherence to Mediterranean diet: results from the Moli-sani study. Nutrients. 2013; 5: 4364-4379.
11. Tseng M, Sellers TA, Vierkant RA, Kushi LH, Vachon CM. Mediterranean diet and breast density in the Minnesota Breast Cancer Family Study. Nutr Cancer. 2008; 60: 703-709.
12. Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med. 2006; 354: 270-282.
13. Trichopoulou A, Bamia C, Lagiou P, Trichopoulos D. Conformity to traditional Mediterranean diet and breast cancer risk in the Greek EPIC (European Prospective Investigation into Cancer and Nutrition) cohort. Am J Clin Nutr. 2010; 92: 620-625.
14. La Vecchia C, Bosetti C. Diet and cancer risk in Mediterranean countries: open issues. Public Health Nutr. 2006; 9: 1077-1082.
15. Allen NE, Grace PB, Ginn A, Travis RC, Roddam AW, Appleby PN, et al. Phytanic acid: measurement of plasma concentrations by gas-liquid chromatography-mass spectrometry analysis and associations with diet and other plasma fatty acids. Br J Nutr. 2008; 99: 653-659.
16. Menéndez JA, Vázquez-Martín A, Ropero S, Colomer R, Lupu R. HER2 (erbB-2)-targeted effects of the omega-3 polyunsaturated fatty acid, alpha-linolenic acid (ALA; 18:3n-3), in breast cancer cells: the “fat features” of the “Mediterranean diet” as an “anti-HER2 cocktail”. Clin TranslOncol. 2006; 8: 812-820.
17. Menendez JA, Vazquez-Martin A, Garcia-Villalba R, Carrasco-Pancorbo A, Oliveras-Ferraros C, Fernandez-Gutierrez A, et al. ta-bAnti-HER2 (erbB-2) oncogene effects of phenolic compounds directly isolated from commercial Extra-Virgin Olive Oil (EVOO). BMC Cancer. 2008; 8: 377.
18. Carruba G, Granata OM, Pala V, Campisi I, Agostara B, Cusimano R, et al. A traditional Mediterranean diet decreases endogenous estrogens in healthy postmenopausal women. Nutr Cancer. 2006; 56: 253-259.
19. Cottet V, Touvier M, Fournier A, Touillaud MS, Lafay L, Clavel-Chapelon F, et al. Postmenopausal breast cancer risk and dietary patterns in the E3N-EPIC prospective cohort study. Am J Epidemiol. 2009; 170: 1257-1267.
20. Cade JE, Taylor EF, Burley VJ, Greenwood DC. Does the Mediterranean dietary pattern or the healthy diet index influence the risk of breast cancer in a large British cohort of women? Eur J Clin Nutr. 2011; 65: 920-928.
21. Castello A, Pollan M, Buijsse B, Ruiz A, Casas AM, et al. Spanish Mediterranean diet and other dietary patterns and breast cancer risk: case-control EpiGEICAM study. Br J Cancer. 2014; 111: 1454-1462.
22. Murtaugh MA, Sweeney C, Giuliano AR, Herrick JS, Hines L, Byers T, et al. Diet patterns and breast cancer risk in Hispanic and non-Hispanic white women: The four-corners breast cancer study. Am J Clin Nutr. 2008; 87: 978-984.
23. Leung G, Baggott C, West C, Elboim C, Paul SM, Cooper BA, et al. Cytokine candidate genes predict the development of secondary lymphedema following breast cancer surgery. Lymphat Res Biol. 30. 2014; 12: 10-22.
24. Hulka BS, Moorman PG. Breast cancer: hormones and other risk factors. Maturitas. 2008; 61: 203-213.
25. Trichopoulos D, Adami HO, Ekbom A, Hsieh CC, Lagiou P. Early life events and conditions and breast cancer risk: from epidemiology to etiology. Int J Cancer. 2008; 122: 481-485.
26. Menendez JA, Vellon L, Colomer R, Lupu R. Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin) in breast cancer cells with Her-2/neu oncogene amplification. Ann Oncol. 2005; 16: 359-371.
27. Warleta F, Campos M, Allouche Y, Sánchez-Quesada C, Ruiz-Mora J, Beltrán G, et al. Squalene protects against oxidative DNA damage in MCF10A human mammary epithelial cells but not in MCF7 and MDA-MB-231 human breast cancer cells. FoodChemToxicol. 2010; 48: 1092-1100.
28. Khodarahmi M, Azadbakht L. The association between different kinds of fat intake and breast cancer risk in women. Int J Prev Med. 2014; 5: 6-15.
29. Cross AJ, Leitzmann MF, Gail MH, Hollenbeck AR, Schatzkin A, Sinha R. A prospective study of red and processed meat intake in relation to cancer risk. PLoSMed. 2007; 4: e325.
30. Zheng JS, Hu XJ, Zhao YM, Yang J, Li D. Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: metaanalysis of data from 21 independent prospective cohort studies. BMJ. 2013; 346: f3706.
31. Seitz HK, Pelucchi C, Bagnardi V, La Vecchia C. Epidemiology and pathophysiology of alcohol and breast cancer: Update 2012. Alcohol Alcohol. 2012; 47: 204-212.
32. Wang Y, Lee KW, Chan FL, Chen S, Leung LK. The red wine polyphenol resveratrol displays bi-level inhibition on aromatase in breast cancer cells. ToxicolSci. 2006; 92: 71-77.